Arachidonic Acid Treatment Against Schistosomiasis Infection in Children

NACompletedINTERVENTIONAL
Enrollment

335

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

July 31, 2013

Study Completion Date

January 31, 2014

Conditions
SchistosomiasisBilharzia
Interventions
DRUG

Praziquantel (PZQ)

"40 mg/kg, a single dose, administered orally~1 g of corn/soybean oil (50%/50%), administered orally"

DIETARY_SUPPLEMENT

Arachidonic acid (ARA)

ARA (40% of total fatty acid)

DIETARY_SUPPLEMENT

PZQ+ARA

A single dose of PZQ administered seven days in advance of initial treatment with ARA.

Trial Locations (3)

Unknown

National Liver Institute, Menoufiya University,, Shebin El-Kom

Tropical Health Department, High Institute of Public Health, Alexandria University, Alexandria

Cairo University, Cairo

All Listed Sponsors
collaborator

National Liver Institute, Egypt

OTHER

collaborator

Cairo University

OTHER

collaborator

High Institute of Public Health, Egypt

OTHER

lead

DSM Nutritional Products, Inc.

INDUSTRY

NCT02144389 - Arachidonic Acid Treatment Against Schistosomiasis Infection in Children | Biotech Hunter | Biotech Hunter